June 15, 2026

Fleming Initiative and Cepheid begin TRACE-CPE study on rapid CPE testing

​The Fleming Initiative and Cepheid have begun the TRACE-CPE research study aimed at improving testing for antimicrobial resistance.The post Fleming...

June 12, 2026

First patient treated in Airiver Medical’s RESTORE-2 trial for CRS

​Airiver Medical has treated the first patient in its RESTORE-2 pivotal clinical trial assessing the ESSpand Sinus DCB for CRS.The...

June 12, 2026

Novo Nordisk identifies unauthorised data access from trials

​Novo Nordisk has identified that certain patient data from some of its clinical trials was accessed and copied externally in...

June 12, 2026

FDA grants priority review for Roche’s Tecentriq combo sBLA

​Roche has received the FDA priority review for its sBLA for adjuvant Tecentriq and Tecentriq Hybreza in combination with chemotherapy...

June 11, 2026

Sibel Health’s ANNE One platform secures EU MDR CE mark

​Sibel Health has received CE mark certification under the EU MDR for its ANNE One system, designating it as a...

June 11, 2026

CONNECTA Therapeutics begins Phase IIa trial of CTH120 for FXS

​CONNECTA Therapeutics has started a Phase IIa trial to assess CTH120, a neuroplasticity modulator, in adult males with fragile X...

June 11, 2026

EMA validates Bayer’s asundexian application for ischaemic stroke

​The EMA has validated Bayer's marketing authorisation application for asundexian, an oral Factor XIa inhibitor, to prevent ischaemic stroke.The post...

June 10, 2026

MHRA to roll out new AI sandbox for medicines development 

​The UK’s MHRA has announced plans to launch a new AI sandbox to expedite the development of medicines and improve...

June 10, 2026

Windward Bio doses first patients in Phase II SIRIUS COPD trial

​Harbour BioMed’s partner Windward Bio has dosed the first patients in the Phase II SIRIUS trial with SKB378 to treat...

Connect with us

Whether you are a professional looking for a new job or a representative of an organization who needs workforce solutions - we are here to help.